Amgen Inc WCLC Data Highlights Investor Call Transcript
My name is Cindy, and I'll be your conference facilitator today for Amgen's conference call from the World Conference on Lung Cancer. (Operator Instructions) And I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.
Okay. Thank you, Cindy, and good evening, everybody. So let me begin by thanking you for taking the time on a Friday evening to participate in our session. My initial logic was to conduct this session as close as possible to the presentation of our sotorasib Phase II data in the scientific session at the World Lung Conference. But as you know, we ended up putting out a press release yesterday containing most of the data as there was a media leak of embargoed material. Regardless, we are delighted that you can join us.
We are pleased with the progress we have made with this program on several dimensions: the speed with which we have gone from first-in-human to NDA submission; quality of the data having undertaken an intent-to-treat analysis and central
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
